Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: JanyBlueEyes who wrote (1626)	4/1/1998 1:36:00 PM
From: Tensane 1	Read Replies (1) \| Respond to of 5736

Jane, After reading the the announcement on the completion of studies for new medical application in dermatology, I was confused. Is this the same machine that detects billiruben? For a clarification, I called the company and what they said is that the patented technology is the same, all that needs to be changed are some minor changes in the software and you can concievably use it for other medical applications--pretty much what Skip has already said, but it was good to hear it from the source. What, of course, this means is that once the clinical trials are completed,and we get the additional FDA clearance, (it should go much faster because the FDA has already approved the base technology), we open up another HUGE market potential. Am I missing something here, or don't we have the potential for mulitiple machines in a hospital? Possibility of a machine in many different specialists office? Is this your take also? Kevin